Glioma cell dispersion is driven by α5 integrin-mediated cell-matrix and cell-cell interactions

Cancer Letters

Volumn 376, Issue 2, 2016, Pages 328-338

  Blandin, Anne Florence ^a   Noulet, Fanny ^a   Renner, Guillaume ^a   Mercier, Marie Cécile ^a   Choulier, Laurence ^a   Vauchelles, Romain ^a   Ronde, Philippe ^a   Carreiras, Franck ^b   Etienne Selloum, Nelly ^a,d   Vereb, Gyorgy ^c   Lelong Rebel, Isabelle ^a   Martin, Sophie ^a   Dontenwill, Monique ^a   Lehmann, Maxime ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIVERSITÉ DE CERGY PONTOISE   (France)

^c UNIVERSITY OF DEBRECEN   (Hungary)

^d CENTRE PAUL STRAUSS   (France)

Author keywords

Fibronectin; Focal adhesion kinase; Glioblastoma; Integrin; Migration

Indexed keywords

ALPHA5 INTEGRIN; FIBRONECTIN; FIBRONECTIN RECEPTOR; CD51 ANTIGEN; FOCAL ADHESION KINASE 1; PTK2 PROTEIN, HUMAN;

ARTICLE; BRAIN TISSUE; CELL ADHESION; CELL INTERACTION; CELL INVASION; CELL JUNCTION; CELL MIGRATION; CONTROLLED STUDY; DRUG TARGETING; EXTRACELLULAR MATRIX; GLIOMA CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; PRIORITY JOURNAL; TUMOR CELL; TUMOR MICROENVIRONMENT; TUMOR SPHEROID; BRAIN TUMOR; CELL COMMUNICATION; CELL MOTION; FOCAL ADHESION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MULTICELLULAR SPHEROID; PATHOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTOR; TUMOR CELL LINE; TUMOR INVASION;

BRAIN NEOPLASMS; CELL ADHESION; CELL COMMUNICATION; CELL LINE, TUMOR; CELL MOVEMENT; CELL-MATRIX JUNCTIONS; EXTRACELLULAR MATRIX; FIBRONECTINS; FOCAL ADHESION KINASE 1; HUMANS; INTEGRIN ALPHAV; NEOPLASM INVASIVENESS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SPHEROIDS, CELLULAR; TIME FACTORS; TRANSFECTION;

EID: 84963612051     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2016.04.007     Document Type: Article

References (62)

1. Nakada M., Nakada S., Demuth T., Tran N.L., Hoelzinger D.B., Berens M.E. Molecular targets of glioma invasion. Cell. Mol. Life Sci 2007, 64:458-478. 10.1007/s00018-007-6342-5.
2. Vehlow A., Cordes N. Invasion as target for therapy of glioblastoma multiforme. Biochim. Biophys. Acta 1836, 2013:236-244. 10.1016/j.bbcan.2013.07.001.
3. Montana V., Sontheimer H. Bradykinin promotes the chemotactic invasion of primary brain tumors. J. Neurosci 2011, 31:4858-4867. 10.1523/JNEUROSCI.3825-10.2011.
4. Hirata E., Yukinaga H., Kamioka Y., Arakawa Y., Miyamoto S., Okada T., et al. In vivo fluorescence resonance energy transfer imaging reveals differential activation of Rho-family GTPases in glioblastoma cell invasion. J. Cell Sci 2012, 125:858-868. 10.1242/jcs.089995.
5. Bellail A.C., Hunter S.B., Brat D.J., Tan C., Van Meir E.G. Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int. J. Biochem. Cell Biol 2004, 36:1046-1069. 10.1016/j.biocel.2004.01.013.
6. Silver D.J., Siebzehnrubl F.A., Schildts M.J., Yachnis A.T., Smith G.M., Smith A.A., et al. Chondroitin sulfate proteoglycans potently inhibit invasion and serve as a central organizer of the brain tumor microenvironment. J. Neurosci 2013, 33:15603-15617. 10.1523/JNEUROSCI.3004-12.2013.
7. Lal A., Lash A.E., Altschul S.F., Velculescu V., Zhang L., McLendon R.E., et al. A public database for gene expression in human cancers. Cancer Res 1999, 59:5403-5407.
8. Castellani P., Borsi L., Carnemolla B., Birò A., Dorcaratto A., Viale G.L., et al. Differentiation between high- and low-grade astrocytoma using a human recombinant antibody to the extra domain-B of fibronectin. Am. J. Pathol 2002, 161:1695-1700.
9. Mahesparan R., Read T.-A., Lund-Johansen M., Skaftnesmo K.O., Bjerkvig R., Engebraaten O. Expression of extracellular matrix components in a highly infiltrative in vivo glioma model. Acta Neuropathol 2003, 105:49-57. 10.1007/s00401-002-0610-0.
10. Serres E., Debarbieux F., Stanchi F., Maggiorella L., Grall D., Turchi L., et al. Fibronectin expression in glioblastomas promotes cell cohesion, collective invasion of basement membrane in vitro and orthotopic tumor growth in mice. Oncogene 2014, 33:3451-3462. 10.1038/onc.2013.305.
11. Ohnishi T., Hiraga S., Izumoto S., Matsumura H., Kanemura Y., Arita N., et al. Role of fibronectin-stimulated tumor cell migration in glioma invasion in vivo: clinical significance of fibronectin and fibronectin receptor expressed in human glioma tissues. Clin. Exp. Metastasis 1998, 16:729-741. 10.1023/A:1006532812408.
12. Yuan L., Siegel M., Choi K., Khosla C., Miller C.R., Jackson E.N., et al. Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy. Oncogene 2007, 26:2563-2573. 10.1038/sj.onc.1210048.
13. Serres E., Debarbieux F., Stanchi F., Maggiorella L., Grall D., Turchi L., et al. Fibronectin expression in glioblastomas promotes cell cohesion, collective invasion of basement membrane in vitro and orthotopic tumor growth in mice. Oncogene 2013, 33:3451-3462. 10.1038/onc.2013.305.
14. Sengupta S., Nandi S., Hindi E.S., Wainwright D.A., Han Y., Lesniak M.S. Short hairpin RNA-mediated fibronectin knockdown delays tumor growth in a mouse glioma model. Neoplasia 2010, 12:837.
15. Ohnishi T., Arita N., Hiraga S., Taki T., Izumoto S., Fukushima Y., et al. Fibronectin-mediated cell migration promotes glioma cell invasion through chemokinetic activity. Clin. Exp. Metastasis 1997, 15:538-546.
16. Blandin A.-F., Renner G., Lehmann M., Lelong-Rebel I., Martin S., Dontenwill M. β1 integrins as therapeutic targets to disrupt hallmarks of cancer. Front Pharmacol 2015, 279. 10.3389/fphar.2015.00279.
17. Gingras M.C., Roussel E., Bruner J.M., Branch C.D., Moser R.P. Comparison of cell adhesion molecule expression between glioblastoma multiforme and autologous normal brain tissue. J. Neuroimmunol 1995, 57:143-153.
18. Cosset E.C., Godet J., Entz-Werlé N., Guérin E., Guenot D., Froelich S., et al. Involvement of the TGFβ pathway in the regulation of α(5) β(1) integrins by caveolin-1 in human glioblastoma. Int. J. Cancer 2012, 131:601-611. 10.1002/ijc.26415.
19. Janouskova H., Maglott A., Leger D.Y., Bossert C., Noulet F., Guerin E., et al. Integrin α5β1 plays a critical role in resistance to temozolomide by interfering with the p53 pathway in high-grade glioma. Cancer Res 2012, 72:3463-3470. 10.1158/0008-5472.CAN-11-4199.
20. Holmes K.M., Annala M., Chua C.Y.X., Dunlap S.M., Liu Y., Hugen N., et al. Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-κB network. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:3475-3480. 10.1073/pnas.1120375109.
21. Lathia J.D., Li M., Sinyuk M., Alvarado A.G., Flavahan W.A., Stoltz K., et al. High-throughput flow cytometry screening reveals a role for junctional adhesion molecule a as a cancer stem cell maintenance factor. Cell Rep 2014, 6:117-129. 10.1016/j.celrep.2013.11.043.
22. Mallawaaratchy D.M., Buckland M.E., McDonald K.L., Li C.C.Y., Ly L., Sykes E.K., et al. Membrane proteome analysis of glioblastoma cell invasion. J. Neuropathol. Exp. Neurol 2015, 74:425-441. 10.1097/NEN.0000000000000187.
23. Schaffner F., Ray A.M., Dontenwill M. Integrin α5β1, the fibronectin receptor, as a pertinent therapeutic target in solid tumors. Cancers (Basel) 2013, 5:27-47. 10.3390/cancers5010027.
24. Renner G., Janouskova H., Noulet F., Koenig V., Guerin E., Bär S., et al. Integrin α5β1 and p53 convergent pathways in the control of anti-apoptotic proteins PEA-15 and survivin in high-grade glioma. Cell Death Differ 2015, 23:640-653. 10.1038/cdd.2015.131.
25. Martinkova E., Maglott A., Leger D.Y., Bonnet D., Stiborova M., Takeda K., et al. alpha5beta1 integrin antagonists reduce chemotherapy-induced premature senescence and facilitate apoptosis in human glioblastoma cells. Int. J. Cancer 2010, 127:1240-1248. 10.1002/ijc.25187.
26. Schwarzbauer J.E., DeSimone D.W. Fibronectins, their fibrillogenesis, and in vivo functions. Cold Spring Harb. Perspect. Biol 2011, 3:a005041. 10.1101/cshperspect.a005041.
27. Katz B.-Z., Zamir E., Bershadsky A., Kam Z., Yamada K.M., Geiger B. Physical state of the extracellular matrix regulates the structure and molecular composition of cell-matrix adhesions. Mol. Biol. Cell 2000, 11:1047-1060. 10.1091/mbc.11.3.1047.
28. Pankov R., Cukierman E., Katz B.-Z., Matsumoto K., Lin D.C., Lin S., et al. Integrin dynamics and matrix assembly tensin-dependent translocation of α5β1 integrins promotes early fibronectin fibrillogenesis. J. Cell Biol 2000, 148:1075-1090. 10.1083/jcb.148.5.1075.
29. Ray A.-M., Schaffner F., Janouskova H., Noulet F., Rognan D., Lelong-Rebel I., et al. Single cell tracking assay reveals an opposite effect of selective small non-peptidic α5β1 or αvβ3/β5 integrin antagonists in U87MG glioma cells. Biochim. Biophys. Acta 2014, 1840:2978-2987. 10.1016/j.bbagen.2014.04.024.
30. Martin S., Cosset E.C., Terrand J., Maglott A., Takeda K., Dontenwill M. Caveolin-1 regulates glioblastoma aggressiveness through the control of alpha(5)beta(1) integrin expression and modulates glioblastoma responsiveness to SJ749, an alpha(5)beta(1) integrin antagonist. Biochim. Biophys. Acta 2009, 1793:354-367. 10.1016/j.bbamcr.2008.09.019.
31. Robinson E.E., Foty R.A., Corbett S.A. Fibronectin matrix assembly regulates α5β1-mediated cell cohesion. Mol. Biol. Cell 2004, 15:973-981. 10.1091/mbc.E03-07-0528.
32. Sabari J., Lax D., Connors D., Brotman I., Mindrebo E., Butler C., et al. Fibronectin matrix assembly suppresses dispersal of glioblastoma cells. PLoS ONE 2011, 6:e24810. 10.1371/journal.pone.0024810.
33. Singh P., Schwarzbauer J.E. Fibronectin matrix assembly is essential for cell condensation during chondrogenesis. J. Cell Sci 2014, 127:4420-4428. 10.1242/jcs.150276.
34. Lehmann M., Rabenandrasana C., Tamura R., Lissitzky J.C., Quaranta V., Pichon J., et al. A monoclonal antibody inhibits adhesion to fibronectin and vitronectin of a colon carcinoma cell line and recognizes the integrins alpha v beta 3, alpha v beta 5, and alpha v beta 6. Cancer Res 1994, 54:2102-2107.
35. Carduner L., Agniel R., Kellouche S., Picot C.R., Blanc-Fournier C., Leroy-Dudal J., et al. Ovarian cancer ascites-derived vitronectin and fibronectin: combined purification, molecular features and effects on cell response. Biochim. Biophys. Acta 2013, 1830:4885-4897. 10.1016/j.bbagen.2013.06.023.
36. Schneider C.A., Rasband W.S., Eliceiri K.W. NIH image to ImageJ: 25 years of image analysis. Nat. Methods 2012, 9:671-675. 10.1038/nmeth.2089.
37. Bolte S., Cordelières F.P. A guided tour into subcellular colocalization analysis in light microscopy. J. Microsc 2006, 224:213-232. 10.1111/j.1365-2818.2006.01706.x.
38. Hirschhaeuser F., Menne H., Dittfeld C., West J., Mueller-Klieser W., Kunz-Schughart L.A. Multicellular tumor spheroids: an underestimated tool is catching up again. J. Biotechnol 2010, 148:3-15. 10.1016/j.jbiotec.2010.01.012.
39. Jia D., Entersz I., Butler C., Foty R.A. Fibronectin matrix-mediated cohesion suppresses invasion of prostate cancer cells. BMC Cancer 2012, 12:94. 10.1186/1471-2407-12-94.
40. Salmenperä P., Kankuri E., Bizik J., Sirén V., Virtanen I., Takahashi S., et al. Formation and activation of fibroblast spheroids depend on fibronectin-integrin interaction. Exp. Cell Res 2008, 314:3444-3452. 10.1016/j.yexcr.2008.09.004.
41. Robinson E.E., Zazzali K.M., Corbett S.A., Foty R.A. α5β1 integrin mediates strong tissue cohesion. J. Cell Sci 2003, 116:377-386. 10.1242/jcs.00231.
42. Clark K., Pankov R., Travis M.A., Askari J.A., Mould A.P., Craig S.E., et al. A specific α5β1-integrin conformation promotes directional integrin translocation and fibronectin matrix formation. J. Cell Sci 2005, 118:291-300. 10.1242/jcs.01623.
43. Hamadi A., Bouali M., Dontenwill M., Stoeckel H., Takeda K., Rondé P. Regulation of focal adhesion dynamics and disassembly by phosphorylation of FAK at tyrosine 397. J. Cell Sci 2005, 118:4415-4425. 10.1242/jcs.02565.
44. da Rocha-Azevedo B., Grinnell F. Fibroblast morphogenesis on 3D collagen matrices: the balance between cell clustering and cell migration. Exp. Cell Res 2013, 319:2440-2446. 10.1016/j.yexcr.2013.05.003.
45. Ryan P.L., Foty R.A., Kohn J., Steinberg M.S. Tissue spreading on implantable substrates is a competitive outcome of cell-cell vs. cell-substratum adhesivity. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:4323-4327. 10.1073/pnas.071615398.
46. Weiswald L.-B., Bellet D., Dangles-Marie V. Spherical cancer models in tumor biology. Neoplasia 2015, 17:1-15. 10.1016/j.neo.2014.12.004.
47. Ivascu A., Kubbies M. Diversity of cell-mediated adhesions in breast cancer spheroids. Int. J. Oncol 2007, 31:1403-1413.
48. Saias L., Gomes A., Cazales M., Ducommun B., Lobjois V. Cell-cell adhesion and cytoskeleton tension oppose each other in regulating tumor cell aggregation. Cancer Res 2015, 75:2426-2433. 10.1158/0008-5472.CAN-14-3534.
49. Casey R.C., Burleson K.M., Skubitz K.M., Pambuccian S.E., Oegema T.R., Ruff L.E., et al. β1-Integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids. Am. J. Pathol 2001, 159:2071-2080. 10.1016/S0002-9440(10)63058-1.
50. Mao Y., Schwarzbauer J.E. Fibronectin fibrillogenesis, a cell-mediated matrix assembly process. Matrix Biol 2005, 24:389-399. 10.1016/j.matbio.2005.06.008.
51. Cukierman E., Pankov R., Stevens D.R., Yamada K.M. Taking cell-matrix adhesions to the third dimension. Science 2001, 294:1708-1712. 10.1126/science.1064829.
52. Winters B.S., Raj B.M., Robinson E.E., Foty R.A., Corbett S.A. Three-dimensional culture regulates Raf-1 expression to modulate fibronectin matrix assembly. Mol. Biol. Cell 2006, 17:3386-3396.
53. Fernandez-Sauze S., Grall D., Cseh B., Van Obberghen-Schilling E. Regulation of fibronectin matrix assembly and capillary morphogenesis in endothelial cells by Rho family GTPases. Exp. Cell Res 2009, 315:2092-2104. 10.1016/j.yexcr.2009.03.017.
54. Zhong C., Chrzanowska-Wodnicka M., Brown J., Shaub A., Belkin A.M., Burridge K. Rho-mediated contractility exposes a cryptic site in fibronectin and induces fibronectin matrix assembly. J. Cell Biol 1998, 141:539-551. 10.1083/jcb.141.2.539.
55. Vouret-Craviari V., Boulter E., Grall D., Matthews C., Obberghen-Schilling E.V. ILK is required for the assembly of matrix-forming adhesions and capillary morphogenesis in endothelial cells. J. Cell Sci 2004, 117:4559-4569. 10.1242/jcs.01331.
56. Ilić D., Kovačič B., Johkura K., Schlaepfer D.D., Tomašević N., Han Q., et al. FAK promotes organization of fibronectin matrix and fibrillar adhesions. J. Cell Sci 2004, 117:177-187. 10.1242/jcs.00845.
57. Skau C.T., Plotnikov S.V., Doyle A.D., Waterman C.M. Inverted formin 2 in focal adhesions promotes dorsal stress fiber and fibrillar adhesion formation to drive extracellular matrix assembly. Proc. Natl. Acad. Sci. U.S.A. 2015, 112:E2447-E2456. 10.1073/pnas.1505035112.
58. Sottile J., Chandler J. Fibronectin matrix turnover occurs through a caveolin-1-dependent process. Mol. Biol. Cell 2005, 16:757-768. 10.1091/mbc.E04-08-0672.
59. Shi F., Sottile J. MT1-MMP regulates the turnover and endocytosis of extracellular matrix fibronectin. J. Cell Sci 2011, 124:4039-4050. 10.1242/jcs.087858.
60. Takino T., Nagao R., Manabe R., Domoto T., Sekiguchi K., Sato H. Membrane-type 1 matrix metalloproteinase regulates fibronectin assembly to promote cell motility. FEBS Lett 2011, 585:3378-3384. 10.1016/j.febslet.2011.09.039.
61. Riemenschneider M.J., Mueller W., Betensky R.A., Mohapatra G., Louis D.N. In situ analysis of integrin and growth factor receptor signaling pathways in human glioblastomas suggests overlapping relationships with focal adhesion kinase activation. Am. J. Pathol 2005, 167:1379-1387.
62. Jülich D., Cobb G., Melo A.M., McMillen P., Lawton A.K., Mochrie S.G.J., et al. Cross-scale integrin regulation organizes ECM and tissue topology. Dev. Cell 2015, 34:33-44. 10.1016/j.devcel.2015.05.005.